Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.

Same-day discharge after PCI for NSTE-ACS is on the rise

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings.

‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately. 

court judge gavel business man bankruptcy lawsuit

Judge blocks Edwards’ JenaValve acquisition—FTC calls it a ‘major win’ for Trump administration

The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed. 

Thumbnail

FDA announces supplement recall over risk of heart attack or stroke

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Nirat Beohar, MD, director, cardiac catheterization laboratory, medical director of the structural heart disease program, Mount Sinai Medical Center in Miami Beach, Florida, and a professor at the Columbia University Division of Cardiology, explains the financial landscape of the cath lab, what is ahead, and why cardiologists need to become more business savvy. #TCT

The business of cardiology is changing—and cath labs are working to keep up

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

Thumbnail

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

leg veins chronic venous disease PAD peripheral artery disease

Cardiovascular health societies share new performance and quality measures for PAD management

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

Displaying 25 - 32 of 7001
Design by Adaptive Theme